← Back to Search

Transcranial Magnetic Stimulation for Spinal Cord Injury (uMEP Trial)

N/A
Recruiting
Led By Blair Dellenbach, MSOT
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and final training session (approximately 2.5 months)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if transcranial magnetic stimulation can help improve movement in people with incomplete spinal cord injury.

Who is the study for?
This trial is for individuals with incomplete spinal cord injury who are over 6 months post-injury, medically stable, and not expecting medication changes for 3 months. They must have weak wrist extension but can still move their arm voluntarily. People with motoneuron injuries, cognitive impairments, seizures, metal in the skull, pregnancy or certain implants cannot join.
What is being tested?
The study tests if training the brain-to-muscle pathway using a magnetic stimulator improves arm movement in those with spinal cord injuries. Participants will train their wrist extensor muscle response to this stimulation over 30 visits lasting about 1.5 hours each.
What are the potential side effects?
Using transcranial magnetic stimulation may cause little to no discomfort; however specific side effects aren't detailed here. It's generally considered safe but could potentially trigger headaches or scalp sensations at the site of stimulation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and final training session (approximately 2.5 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and final training session (approximately 2.5 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in ability to move the arm as measured by the Action Research Arm Test (ARAT). Maximum score of 57 points
Change in ability to move the arm as measured by the Fugl-Meyer Assessment (FMA)
Change in fine motor ability and finger dexterity as measured by the Nine Hole Peg Test
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MEP Wrist Extensor Up-ConditioningExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
973 Previous Clinical Trials
7,399,379 Total Patients Enrolled
1 Trials studying Quadriplegia
19 Patients Enrolled for Quadriplegia
Blair Dellenbach, MSOTPrincipal InvestigatorMedical University of South Carolina

Media Library

MEP Operant Up-conditioning of the Wrist Extensor Clinical Trial Eligibility Overview. Trial Name: NCT05321017 — N/A
Quadriplegia Research Study Groups: MEP Wrist Extensor Up-Conditioning
Quadriplegia Clinical Trial 2023: MEP Operant Up-conditioning of the Wrist Extensor Highlights & Side Effects. Trial Name: NCT05321017 — N/A
MEP Operant Up-conditioning of the Wrist Extensor 2023 Treatment Timeline for Medical Study. Trial Name: NCT05321017 — N/A
~1 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top